|
| 1 |
Chemosensitizing effect and mechanism of imperatorin on the anti-tumor activity of doxorubicin in tumor cells and transplantation tumor model
Xin-li Liang, Miao-miao Ji, Zheng-gen Liao, Guo-wei Zhao, Xi-lan Tang, Wei Dong
|
|
| 2 |
Protective effects and mechanism of coenzyme Q10 and vitamin C on doxorubicin-induced gastric mucosal injury and effects of intestinal flora
Xiaomeng Zhao, Xueke Feng, Nan Ye, Panpan Wei, Zhanwei Zhang, Wenyu Lu
|
|
| 3 |
Effect of meloxicam (cyclooygenase-2 inhibitor) versus vitamin D3 (cholecalciferol) as ameliorating agents of progressive doxorubicin-induced nephrotoxicity in rats
Dalia Mahmoud Abdelmonem Elsherbini, Hasnaa Ali Ebrahim
Anat Cell Biol.2020;53(2):169-182. Published online 2020 June 30
DOI: http://dx.doi.org/10.5115/acb.19.231
|
|
| 4 |
Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
Chyong-Huey Lai, Elizabeth Vallikad, Hao Lin, Lan-Yan Yang, Shih-Ming Jung, Hsueh-Erh Liu, Yu-Che Ou, Hung-Hsueh Chou, Cheng-Tao Lin, Huei-Jean Huang, Kuan-Gen Huang, Jiantai Qiu, Yao-Ching Hung, Tzu-I Wu, Wei-Yang Chang, Kien-Thiam Tan, Chiao-Yun Lin, Angel Chao, Chee-Jen Chang
|
|
| 5 |
Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer
Jian Gao, Fusheng Deng, Weidong Jia
|
|
| 6 |
Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway
Chien-Liang Liu, Ming-Jen Chen, Jiunn-Chang Lin, Chi-Hsin Lin, Wen-Chien Huang, Shih-Ping Cheng, Shan-Na Chen, Yuan-Ching Chang
|
|
| 7 |
Differential antitumor effects of sequence-dependent model in tumor cell line: association with peroxiredoxin
Hee Young Cho, Gyeongwon Lee, Junghun Kang, Young Sool Hah, Joung Soon Jang
|
|
| 8 |
The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience
Young-Jae Lee, Yong-Man Kim, Shin-Wha Lee, Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Young-Tak Kim, Joo-Hyun Nam
|
|
| 9 |
Comparision of doxorubicin-induced cardiotoxicity in the ICR mice of different sources
Sou Hyun Kim, Keuk-Jun Kim, Joung-Hee Kim, Jae-Hwan Kwak, HyunKeun Song, Joon Young Cho, Dae Youn Hwang, Kil Soo Kim, Young-Suk Jung
|
|
| 10 |
Transcatheter Arterial Chemoembolization of Liver Metastasis of Gastrointestinal Leiomyosarcoma
Hyung Jin Won, Jin Wook Chung, Tae Kyoung Kim, Daehee Han, Sun Ho Kim, Jung Eun Cheon, Joon Koo Han, Jae Hyung Park
|
|
| 11 |
Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model
Yun Jung Bae, Young Il Yoon, Tae-Jong Yoon, Hak Jong Lee
|
|
| 12 |
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
Chang Gon Kim, Joohyuk Sohn, Hongjae Chon, Joo Hoon Kim, Su Jin Heo, Hyunsoo Cho, In Jung Kim, Seung Il Kim, Seho Park, Hyung Seok Park, Gun Min Kim
|
|
| 13 |
A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats
Sung-A Chang, Byung-Kwan Lim, You Jung Lee, Mi-Kyung Hong, Jin-Oh Choi, Eun-Seok Jeon
|
|
| 14 |
Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
Hyerim Ha, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo
Cancer Res Treat.2016;48(1):304-311. Published online 2015 April 9
DOI: http://dx.doi.org/10.4143/crt.2014.339
|
|
| 15 |
Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
Yi-Sheng Liu, Ming-Ching Ou, Yi-Shan Tsai, Xi-Zhang Lin, Chien-Kuo Wang, Hong-Ming Tsai, Ming-Tsung Chuang
|
|
| 16 |
Successful Use of a Peripheral Extracorporeal Membrane Oxygenator in a Patient with Chronic Heart Failure and Pneumonia
Ji Hyun Lee, Yang Hyun Cho, Gee Young Suh, Jeong Hoon Yang
|
|
| 17 |
Protective Effect of Survivin in Doxorubicin-Induced Cell Death in H9c2 Cardiac Myocytes
Beom Seob Lee, Soo Hyuk Kim, Taewon Jin, Eun Young Choi, Jaewon Oh, Sungha Park, Sang Hak Lee, Ji Hyung Chung, Seok-Min Kang
|
|
| 18 |
Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells
Fahimeh Aghaee, Jalil Pirayesh Islamian, Behzad Baradaran, Asghar Mesbahi, Mohammad Mohammadzadeh, Mohammad Asghari Jafarabadi
|
|
| 19 |
Early Cardiac Function Monitoring for Detection of Subclinical Doxorubicin Cardiotoxicity in Young Adult Patients with Breast Cancer
Woo-Baek Chung, Jeong-Eun Yi, Jung Yeon Jin, Yun-Seok Choi, Chan Seok Park, Woo-Chan Park, Byung Joo Song, Ho-Joong Youn
|
|
| 20 |
Chemotherapy Response Assay Test and Prognosis for Breast Cancer Patients Who Have Undergone Anthracycline- and Taxane-Based Chemotherapy
Anbok Lee, Woosung Lim, Byung-In Moon, Nam-Sun Paik, Suck-Hwan Koh, Jeong-Yoon Song
J Breast Cancer.2011;14(4):283-288. Published online 2011 December 29
DOI: http://dx.doi.org/10.4048/jbc.2011.14.4.283
|
|
